Kuros Biosciences AG (SWX:KURN)
Switzerland · Delayed Price · Currency is CHF 19.70
-0.40 (-1.99%)
Nov 12, 2026, 5:30 PM CET
Kuros Biosciences AG Market Cap
Kuros Biosciences AG has a market cap or net worth of 784.58 million as of November 12, 2026. It is the 10,291st most valuable company in the world and the 125th biggest in Switzerland. Its market cap has decreased by 25.89% in one year.
Market Cap
784.58M
Enterprise Value
784.85M
Revenue
141.35M
Global Rank
Country Rank
#125 Switzerland
PE Ratio
111.95
ChartMarket Cap Chart
Since January 21, 2016, Kuros Biosciences AG's market cap has decreased from 3.25B to 784.58M, a decrease of -75.86%. That is a compound annual growth rate of -12.31%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 12, 2026 | 784.58M | -27.08% |
| Dec 30, 2025 | 1.08B | 33.56% |
| Dec 30, 2024 | 805.64M | 527.99% |
| Dec 29, 2023 | 128.29M | 138.81% |
| Dec 30, 2022 | 53.72M | -14.90% |
| Dec 30, 2021 | 63.13M | -4.70% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Roche Holding AG | 321.06B |
| Novartis AG | 253.98B |
| Lonza Group AG | 46.17B |
| Galderma Group AG | 43.97B |
| Medartis Holding AG | 1.34B |
| PolyPeptide Group AG | 1.33B |
| Aevis Victoria | 1.21B |
| Idorsia | 1.11B |